glp-1 news october 1 2025 Drugs: Pulse Survey (U.S.) Regulating a "Miracle Drug": GLP-1

The World Health Organization now classifies it as a chronic medical condition, recognizing metabolic and genetic factors that can predispose individuals to the disease

If you prefer non-injectable options at a lower cost, Eden might be for you

Last Published 01.01.2026 Effective Date: 01.01.2026 This policy addresses the use of Luxturna (voretigene neparvovec-rzyl) for the treatment of inherited retinal dystrophies (IRD) caused by mutations in the retinal pigment epithelium-specific protein 65kDa (RPE65) gene

Common Reasons for Stalled Weight Loss on GLP-1 medication When starting on a weight loss journey with GLP-1 medication, its important to maintain realistic expectations for gradual and sustainable progress

Severe adverse reactions are rare but may include anaphylaxis or exacerbation of preexisting conditions

The retail pharmacies segment in the propionic acidemia market is forecasted to hold a notable revenue share by 2035, driven by the convenience retail pharmacies offer for medication access post-discharge